Hoon-Mo Lee

Rednvia Co. Ltd. develops drugs for cardiovascular diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2018. Hoon-Mo Lee has been the CEO of the company since 2019.

Korea Drug Development Fund provides drug development programs. The firm backed by health-related korean ministries like the ministry of science, ICT, future planning, the ministry of trade, industry, energy, the ministry of health and welfare. The company was founded in September 2011 and is headquartered in Seoul, South Korea.

Hollywood Presbyterian Medical Center, Inc. provides health care services. The firm offers cancer and diabetes care, fetal therapy, maternity, orthopedic, pediatric, and neurology. The company was founded in 1924 and is headquartered in Los Angeles, CA.

Part of Cha Biotech Co., Ltd., CHA Health Systems, Inc. is a leader in the biotechnology industry. The company is based in Los Angeles, CA. CHA Health Systems delivers world-class care in all facets of medicine, with a focus on fertility and cutting-edge therapies using cord blood stem cells and immune cells. The company is known for their research and clinical work in these fields. CHA Health Systems consists of 81 hospitals and clinics, 30 research and 14 education institutions, and 31 bio/pharmaceutical/healthcare companies in seven countries. The CEO of the company is Yong-Seok Kim.

Decoy Biosystems, Inc. provides cancer immunotherapy services. The company was founded on August 14, 2013 and is headquartered in San Diego, CA.

Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel.